Sunrest Lifescience has announced a rights issue of 42,91,200 fully paid-up equity shares at an issue price of ₹35 per share, aiming to raise capital from its existing shareholder base. The Board of Directors approved the proposal during a meeting held on August 04, 2026, setting the record date for determining shareholder eligibility as August 10, 2026. This move effectively doubles the company’s outstanding share capital, increasing it from 42,91,200 shares to 85,82,400 shares upon full subscription.

The rights issue carries a premium of ₹25 per share over the face value of ₹10. Shareholders are entitled to one right equity share for every one fully paid-up equity share held on the record date. Eligible shareholders must pay the full amount at the time of application. The Board retains the authority to extend the issue period, provided it does not exceed 30 days from the opening date, and no withdrawals will be permitted after the closing date.

Schedule of Right Issue

Shareholders opting to renounce their rights through off-market transfers must ensure that the entitlements are credited to the renouncees’ demat accounts on or before the issue closing date. On-market renunciations can be completed until August 28, 2026.

Key Terms of the Issue

The announcement was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The detailed terms, including procedural guidelines, will be specified in the Letter of Offer sent to eligible shareholders in due course. This follows an earlier board meeting held on June 26, 2026, where the initial considerations for the rights issue were discussed.

Sunrest Lifescience's board has approved a proposal to raise funds aggregating up to Rs.15.10 crores through a rights issue of fully paid-up equity shares to existing shareholders. The decision was taken during a board meeting held on June 26, 2026. The company intends to issue equity shares with a face value of Rs.10 each to eligible shareholders on a rights basis.

The Draft Letter of Offer for the rights issue was also approved by the board. The specific terms, including the issue price and ratio of shares to be allotted, will be determined by the board at a later date. The record date for determining the eligibility of shareholders is yet to be notified. The total amount raised through this issue will not exceed Rs.15.10 crores.

The rights issue is subject to receiving in-principle approval from the National Stock Exchange of India Limited. The issuance will comply with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The provisions of the Companies Act, 2013, and related rules will also govern the process.

Key Details of the Rights Issue

The following table outlines the key particulars of the proposed issuance as disclosed in the regulatory filing:

The board meeting, which commenced at 11:00 A.M. IST and concluded at 1:00 P.M. IST, also transacted other businesses listed in the agenda circulated to the directors. The disclosure was made to the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.